Literature DB >> 21181300

Rare pediatric adrenocortical carcinoma with oncocytic change: a cytologic dilemma.

Savita Agarwal1, Kiran Agarwal.   

Abstract

Pediatric adrenocortical carcinoma is extremely rare with a prevalence of 0.3 per million. Adrenocortical neoplasms in children usually present with one of the endocrine abnormalities. Adrenocortical neoplasms cannot be easily diagnosed on cytopathology; hence, the cytomorphological features posing diagnostic dilemmas are discussed in a pediatric patient presenting with palpable abdominal mass and virilization. Fine-needle aspiration smears were cellular showing cells in cohesive clusters adhering to central core of capillaries exhibiting an endocrine vascular pattern along with single cells and stripped nuclei. Cells were polygonal in shape and had abundant cytoplasm with well-defined borders and round eccentric nuclei with prominent nucleoli. Marked anisonucleosis was also noted. Few cells showed abundant granular cytoplasm resembling oncocytes. Many bizarre and multinucleated cells, few mitotic figures, and necrosis were also seen. Hematoxylin and eosin-stained sections of tumor biopsy suggested possibility of adrenocortical neoplasm. A panel of immunohistochemical markers were used to exclude possibility of renal cell carcinoma (RCC) and pheochromocytoma that showed vimentin (+), cytokeratin (-), inhibin-α (+), neuron-specific enolase (focally +), and chromogranin (-). The Ki67 index was 15%, and P53 was strongly positive. It is difficult to distinguish adrenocortical neoplasm, RCC, and pheochromocytoma on cytology because of overlapping features; hence, important cytological features which help in distinguishing between the three are discussed.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21181300     DOI: 10.1007/s12022-010-9142-7

Source DB:  PubMed          Journal:  Endocr Pathol        ISSN: 1046-3976            Impact factor:   3.943


  8 in total

Review 1.  Adrenal cortical neoplasms in the pediatric and adolescent age group. Clinicopathologic study of 30 cases with emphasis on epidemiological and prognostic factors.

Authors:  E E Lack; J J Mulvihill; W D Travis; H P Kozakewich
Journal:  Pathol Annu       Date:  1992

2.  Cytomorphology of adrenocortical carcinoma and comparison with renal cell carcinoma.

Authors:  S Sharma; R Singh; K Verma
Journal:  Acta Cytol       Date:  1997 Mar-Apr       Impact factor: 2.319

3.  Immunopathology of adrenal and renal cortical tumors. Coordinated change in antigen expression is associated with neoplastic conversion in the adrenal cortex.

Authors:  R J Cote; C Cordon-Cardo; V E Reuter; P P Rosen
Journal:  Am J Pathol       Date:  1990-05       Impact factor: 4.307

Review 4.  Malignant adrenal tumors.

Authors:  Frederick J Rescorla
Journal:  Semin Pediatr Surg       Date:  2006-02       Impact factor: 2.754

5.  Discerning malignancy in adrenocortical tumors: are molecular markers useful?

Authors:  C Wachenfeld; F Beuschlein; O Zwermann; P Mora; M Fassnacht; B Allolio; M Reincke
Journal:  Eur J Endocrinol       Date:  2001-09       Impact factor: 6.664

Review 6.  Adrenocortical neoplasms in children: radiologic-pathologic correlation.

Authors:  G A Agrons; G J Lonergan; G E Dickey; J E Perez-Monte
Journal:  Radiographics       Date:  1999 Jul-Aug       Impact factor: 5.333

7.  Adrenocortical carcinoma in children: a study of 40 cases.

Authors:  R C Ribeiro; R S Sandrini Neto; M J Schell; L Lacerda; G A Sambaio; I Cat
Journal:  J Clin Oncol       Date:  1990-01       Impact factor: 44.544

Review 8.  Recent advances in histopathology and immunohistochemistry of adrenocortical carcinoma.

Authors:  Hironobu Sasano; Takashi Suzuki; Takuya Moriya
Journal:  Endocr Pathol       Date:  2006       Impact factor: 4.056

  8 in total
  1 in total

1.  Oncocytic adrenocortical tumor with uncertain malignant potential in pediatric population: A case report and review of literature.

Authors:  Xiao-Chun Chen; Yun-Man Tang; Yu Mao; Dao-Rui Qin
Journal:  World J Clin Cases       Date:  2021-07-16       Impact factor: 1.337

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.